ezetimibe/simvastatin teva 10 mg/20 mg tablets
teva b.v. - ezetimibe; simvastatin - tablet - 10/20 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe
ezetimibe/simvastatin teva 10 mg/40 mg tablets
teva b.v. - ezetimibe; simvastatin - tablet - 10/40 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe
ezetimibe/simvastatin teva 10 mg/80 mg tablets
teva b.v. - ezetimibe; simvastatin - tablet - 10/80 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe
pravafen hard capsules 40mg160mg
hyphens pharma pte. ltd. - fenofibrate; pravastatin sodium - capsule - 160mg - fenofibrate 160mg; pravastatin sodium 40mg
sheer sunscreen spf 30 cvs health- avobenzone 2% homosalate 5.5% octisalate 4.5% octocrylene 4% lotion
cvs - avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), homosalate (unii: v06sv4m95s) (homosalate - unii:v06sv4m95s), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm) - avobenzone 2 g in 100 ml - use • helps prevent sunburn
inegy 10 mg/20 mg tablets
pco manufacturing ltd. - ezetimibe; simvastatin - tablet - 10 mg / 20 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe
ezetimibe/simvastatin 10 mg/40 mg tablets
mcdermott laboratories ltd., t/a gerard laboratories - ezetimibe; simvastatin - tablet - 10 mg/40 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe - reductase inhibitors in combination with other lipid modifying agents - it is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familiar and non-familiar) hypercholesterolaemia or mixed hyperlipidaemia, and in patient with hofh
ezetimibe/simvastatin 10mg/20mg tablets
mcdermott laboratories ltd., t/a gerard laboratories - ezetimibe; simvastatin - tablet - 10mg/20 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe - reductase inhibitors in combination with other lipid modifying agents - it is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familiar and non-familiar) hypercholesterolaemia or mixed hyperlipidaemia, and in patient with hofh
ezetimibe/simvastatin 10mg/80mg tablets
mcdermott laboratories ltd., t/a gerard laboratories - ezetimibe; simvastatin - tablet - 10mg/80 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe - reductase inhibitors in combination with other lipid modifying agents - it is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familiar and non-familiar) hypercholesterolaemia or mixed hyperlipidaemia, and in patient with hofh
ezetimibe/simvastatin clonmel 10 mg/10 mg tablets
clonmel healthcare ltd - simvastatin; ezetimibe - tablet - 10/10 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe